Opportunities in the cardiometabolic field are increasing, following a period of limited investment from larger biopharma players. Still, challenges remain, such as accessing funding at the earlier stages of development. 

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.

Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.

In Vivo briefly describes these recently founded companies: Altheos, Amakem, Humedics, Photonics Healthcare, Presage Biosciences and Themis Bioscience.